Welcure Drugs & Pharmaceuticals (BOM:524661) EPS (Basic): ₹-0.01 (TTM As of Mar. 2026)


BOM:524661 Welcure Drugs & Pharmaceuticals Ltd BOM:524661
19 GF Score
Price ₹0.26
! 5 Warning Signs
View Full Analysis

What is Welcure Drugs & Pharmaceuticals EPS (Basic)?

Welcure Drugs & Pharmaceuticals BOM:524661 -3.70% 19 EPS (Basic) is ₹-0.01 as of Mar. 2026. GuruFocus rates BOM:524661 with a GF Score™ of 19/100. The stock has 5 warning signs investors should review.

Welcure Drugs & Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹-0.40. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-0.01.

Welcure Drugs & Pharmaceuticals's EPS (Diluted) for the three months ended in Mar. 2026 was ₹-0.40. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-0.01.

Welcure Drugs & Pharmaceuticals's EPS without NRI for the three months ended in Mar. 2026 was ₹-0.40. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Welcure Drugs & Pharmaceuticals  (BOM:524661) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Welcure Drugs & Pharmaceuticals EPS (Basic) Related Terms

Welcure Drugs & Pharmaceuticals EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Welcure Drugs & Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Welcure Drugs & Pharmaceuticals EPS (Basic) Chart

Welcure Drugs & Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.01 -0.01 0.36 -0.04

Welcure Drugs & Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.19 0.07 0.13 -0.40
BOM:524661
19GF Score
Welcure Drugs & Pharmaceuticals Ltd BOM:524661
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Welcure Drugs & Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Welcure Drugs & Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-54.901-0)/1372.525
=-0.04

Welcure Drugs & Pharmaceuticals's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-498.614-0)/1246.535
=-0.40

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹-0.01 mean?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a EPS (Basic) of ₹-0.01 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Welcure Drugs & Pharmaceuticals and its competitors.
Is Welcure Drugs & Pharmaceuticals' EPS (Basic) too high?
Welcure Drugs & Pharmaceuticals' current EPS (Basic) is ₹-0.01. Overall, Welcure Drugs & Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Welcure Drugs & Pharmaceuticals' EPS (Basic) compare to MCK and COR?
Welcure Drugs & Pharmaceuticals' EPS (Basic) of ₹-0.01 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Distribution company?
A good EPS (Basic) depends on the Medical Distribution industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. Welcure Drugs & Pharmaceuticals's current EPS (Basic) is ₹-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcure Drugs & Pharmaceuticals stock overvalued right now?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a current EPS (Basic) of ₹-0.01. The current EPS (Basic) is ₹-0.01. Welcure Drugs & Pharmaceuticals' overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Welcure Drugs & Pharmaceuticals (BOM:524661), the current EPS (Basic) is ₹-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Welcure Drugs & Pharmaceuticals Business Description

Address Laxmi Nagar, Plot No. 55, Office No. 104, First Floor, Vijay Block, Delhi East, Delhi, Delhi, IND, 110092
Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company operates exclusively in a single business segment: the trading of medical products. The company's revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets.
19GF Score

Get the complete analysis for BOM:524661

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.26
Price